1. Home
  2. HTZ vs AGIO Comparison

HTZ vs AGIO Comparison

Compare HTZ & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HTZ
  • AGIO
  • Stock Information
  • Founded
  • HTZ 1918
  • AGIO 2007
  • Country
  • HTZ United States
  • AGIO United States
  • Employees
  • HTZ N/A
  • AGIO N/A
  • Industry
  • HTZ Rental/Leasing Companies
  • AGIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • HTZ Consumer Discretionary
  • AGIO Health Care
  • Exchange
  • HTZ Nasdaq
  • AGIO Nasdaq
  • Market Cap
  • HTZ 1.3B
  • AGIO 1.4B
  • IPO Year
  • HTZ 1997
  • AGIO 2013
  • Fundamental
  • Price
  • HTZ $6.55
  • AGIO $32.09
  • Analyst Decision
  • HTZ Sell
  • AGIO Buy
  • Analyst Count
  • HTZ 8
  • AGIO 8
  • Target Price
  • HTZ $4.45
  • AGIO $56.00
  • AVG Volume (30 Days)
  • HTZ 11.9M
  • AGIO 550.4K
  • Earning Date
  • HTZ 05-12-2025
  • AGIO 05-01-2025
  • Dividend Yield
  • HTZ N/A
  • AGIO N/A
  • EPS Growth
  • HTZ N/A
  • AGIO N/A
  • EPS
  • HTZ N/A
  • AGIO 11.45
  • Revenue
  • HTZ $8,782,000,000.00
  • AGIO $37,035,000.00
  • Revenue This Year
  • HTZ N/A
  • AGIO $27.43
  • Revenue Next Year
  • HTZ $2.23
  • AGIO $189.81
  • P/E Ratio
  • HTZ N/A
  • AGIO $2.80
  • Revenue Growth
  • HTZ N/A
  • AGIO 25.96
  • 52 Week Low
  • HTZ $2.47
  • AGIO $23.42
  • 52 Week High
  • HTZ $9.39
  • AGIO $62.58
  • Technical
  • Relative Strength Index (RSI)
  • HTZ 50.51
  • AGIO 65.51
  • Support Level
  • HTZ $6.12
  • AGIO $29.05
  • Resistance Level
  • HTZ $7.62
  • AGIO $30.45
  • Average True Range (ATR)
  • HTZ 0.59
  • AGIO 1.13
  • MACD
  • HTZ -0.05
  • AGIO 0.33
  • Stochastic Oscillator
  • HTZ 49.29
  • AGIO 91.98

About HTZ Hertz Global Holdings Inc

Hertz Global Holdings Inc is engaged principally in the business of renting vehicles through Hertz, Dollar and Thrifty brands. The Company has identified two reportable segments: Americas RAC: Rental of vehicles, as well as sales of vehicles and value-added services, in the U.S., Canada, Latin America and the Caribbean; International RAC: Rental of vehicles, as well as sales of vehicles and value-added services, in locations other than the U.S., Canada, Latin America and the Caribbean. The Company maintain a substantial network of company-operated rental locations, a majority of which are in Europe, and have franchisees and partners that operate rental locations under brands. Geographical markets includes U.S., Europe, Pacific Asia, Middle East and Africa, Latin America.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

Share on Social Networks: